Press Releases

= Add Release to Briefcase
All Releases
View Summary Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
05/29/09
PDF 14.8 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice
05/22/09
PDF 13.0 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results
05/14/09
PDF 15.9 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
03/27/09
PDF 17.4 KB Add to Briefcase
View Summary Catalyst to Focus Resources on its Lead Indication for CPP-109; Cocaine Addiction
03/03/09
PDF 13.7 KB Add to Briefcase
View Summary Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
01/09/09
PDF 14.2 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Reports Third Quarter 2008 Financial Results
11/14/08
PDF 16.5 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
11/03/08
PDF 12.2 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
09/12/08
PDF 14.5 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
08/21/08
PDF 14.4 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
08/15/08
PDF 16.1 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
06/30/08
PDF 16.2 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap® Index
06/25/08
PDF 13.7 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
06/03/08
PDF 12.4 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Reports First Quarter 2008 Financial Results
05/16/08
PDF 17.5 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
03/26/08
PDF 17.9 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
03/05/08
PDF 14.0 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
01/25/08
PDF 15.2 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
12/07/07
PDF 15.9 KB Add to Briefcase
View Summary Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
11/14/07
PDF 15.3 KB Add to Briefcase
Showing 1-20 of 41 releases Page: 1 2 3  See Next 20

Stock Information
CPRX NASDAQ
Price: $0.62
Change: - 0.02
07/02/09 2:58 PM ET

Data delayed at least 20 min.
Information provided by eSignal.